Showing results (591-600 of 1,496) with videos related to
Sort By:
Pageof 150
Molecular and Cellular Endocrinology|February 25, 2000
EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathwayB D Gehm, J M McAndrews, V C Jordan, et al.Respiration Physiology|September 29, 2000
Changes in dopamine D(2)-receptor modulation of the hypoxic ventilatory response with chronic hypoxiaK A Huey, I P Brown, M C Jordan, et al.Transplant Immunology|October 30, 2001
Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitroX J Zuo, E Nicolaidou, Y Okada, et al.Pediatric Infectious Disease|January 1, 1985
Circulating immune complexes in Kawasaki syndromeW H Mason, S C Jordan, R Sakai, et al.Transplantation Direct|April 1, 2017
Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular CytotoxicityBong-Ha Shin, Shili Ge, James Mirocha, et al.Stroke|February 14, 2014
Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009Malik M Adil, Adnan I Qureshi, Lauren A Beslow, et al.Oncogene|August 22, 2012
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancerM Razandi, A Pedram, V C Jordan, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|December 12, 2001
Advanced diagnostic methods in oral and maxillofacial pathology. Part I: molecular methodsR C Jordan, T E Daniels, J S Greenspan, et al.Molecular Pharmacology|November 1, 1990
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitroC S Murphy, S M Langan-Fahey, R McCague, et al.Cancer Research|February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifenP M Ravdin, N F Fritz, D C Tormey, et al.Pageof 150